| Traditions Behavioral Health | |
|
1287 Fulton Rd Santa Rosa CA 95401-4923 | |
| (707) 258-8757 | |
| (707) 253-0457 |
| Full Name | Traditions Behavioral Health |
|---|---|
| Speciality | Psychiatry & Neurology |
| Location | 1287 Fulton Rd, Santa Rosa, California |
| Authorized Official Name and Position | Julianne Bharucha (CFO) |
| Authorized Official Contact | 7757623679 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Traditions Behavioral Health 900 Larkspur Landing Cir Ste 160 Larkspur CA 94939-1766 Ph: (707) 258-8757 | Traditions Behavioral Health 1287 Fulton Rd Santa Rosa CA 95401-4923 Ph: (707) 258-8757 |
| NPI Number | 1083802979 |
|---|---|
| Provider Enumeration Date | 10/04/2007 |
| Last Update Date | 08/15/2023 |
| Certification Date | 08/15/2023 |
| Medicare PECOS PAC ID | 8729984539 |
|---|---|
| Medicare Enrollment ID | O20031211000677 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083802979 | NPI | - | NPPES |
| GPS001190 | Medicaid | CA | |
| CA298849 | Other | CA | MEDICARE PTAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | (* (Not Available)) | Primary |
| Provider Name | Larry Charles Lawrence |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1528167061 PECOS PAC ID: 8224923255 Enrollment ID: I20040218000926 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Rick L Jenkins |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1275502825 PECOS PAC ID: 8022093376 Enrollment ID: I20040621001431 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Jonathan A Kistler |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1033161740 PECOS PAC ID: 7214980424 Enrollment ID: I20050228001070 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Ronnie R Cummings |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1255537940 PECOS PAC ID: 1355363938 Enrollment ID: I20051222000722 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Mounir Belcadi |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1053341073 PECOS PAC ID: 9032122486 Enrollment ID: I20060801000318 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Albert U Ma |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1275596496 PECOS PAC ID: 1254332364 Enrollment ID: I20070116000259 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Barrett G Levine |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1114087533 PECOS PAC ID: 2860595634 Enrollment ID: I20070315000276 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Sridhar Prathikanti |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1306920640 PECOS PAC ID: 1658474721 Enrollment ID: I20070920000869 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Vanessa Vianey Hernandez |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1891836425 PECOS PAC ID: 8921160656 Enrollment ID: I20081215000301 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Bruce N Anderson |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1942276324 PECOS PAC ID: 1254230238 Enrollment ID: I20081224000071 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Eric J Khoury |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1972555274 PECOS PAC ID: 3375681885 Enrollment ID: I20091103000412 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Michael H Feddersen |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1871710160 PECOS PAC ID: 2264571728 Enrollment ID: I20091123000699 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Shailesh Gandhi |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1326218686 PECOS PAC ID: 5597733147 Enrollment ID: I20091130000268 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Christopher M Sue |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1639225444 PECOS PAC ID: 0042353583 Enrollment ID: I20100204000906 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Charles D Barton |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1881688505 PECOS PAC ID: 0143229039 Enrollment ID: I20100506000997 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Scott Nichols |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1295989572 PECOS PAC ID: 8325176316 Enrollment ID: I20100512000827 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Pei-huey Nie |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1235317256 PECOS PAC ID: 5890980742 Enrollment ID: I20101117000738 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Gail D Ingram |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1902928302 PECOS PAC ID: 7012932346 Enrollment ID: I20110310000482 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Robert L Oldham |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1356379507 PECOS PAC ID: 3678759735 Enrollment ID: I20110525000622 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Danielle A Lopez |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1144531450 PECOS PAC ID: 3375705197 Enrollment ID: I20120424000234 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Brigitte Apfel |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1073780714 PECOS PAC ID: 3779745716 Enrollment ID: I20120508000680 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Ashraf Ismail |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1720211691 PECOS PAC ID: 2264696749 Enrollment ID: I20120613000324 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Dora-linda L Wang |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1831110071 PECOS PAC ID: 7517059751 Enrollment ID: I20120913000658 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Devin M Stroman |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1811247810 PECOS PAC ID: 0547406415 Enrollment ID: I20130419000106 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Meena Rajendren |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1790927572 PECOS PAC ID: 8820235195 Enrollment ID: I20130503000271 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Megha Miglani |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1861792491 PECOS PAC ID: 9739328527 Enrollment ID: I20130627000436 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Katherine Rose Hulbert |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1225270903 PECOS PAC ID: 0244470102 Enrollment ID: I20130717000631 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Yuliya M Perch |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1043475569 PECOS PAC ID: 3173719150 Enrollment ID: I20130820001041 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Duane Emil Mcwaine |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1629112123 PECOS PAC ID: 2163646712 Enrollment ID: I20140621000005 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Russell Ronald Monroe |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1932237450 PECOS PAC ID: 8820314396 Enrollment ID: I20150226002072 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Suzanna L Freerksen |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1881821791 PECOS PAC ID: 6901069848 Enrollment ID: I20150414002219 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Asher Raphael Gorelik |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1902910649 PECOS PAC ID: 2567528318 Enrollment ID: I20150602000434 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Qyana K Griffith |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1255674495 PECOS PAC ID: 4183935984 Enrollment ID: I20150619002305 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Dustin G Sanchez |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1396063129 PECOS PAC ID: 6709190564 Enrollment ID: I20150806012320 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Mukesh K Sanghadia |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1366550246 PECOS PAC ID: 6800803883 Enrollment ID: I20150901001397 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Safi Ahmed |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1114363876 PECOS PAC ID: 4183933666 Enrollment ID: I20151023000735 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Agnieszka Kalinowski |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1679917678 PECOS PAC ID: 4284944596 Enrollment ID: I20151116002696 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Jonathan B Terry |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1841424728 PECOS PAC ID: 7416189071 Enrollment ID: I20151117000327 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Nancy B Herron |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1780621367 PECOS PAC ID: 9032023387 Enrollment ID: I20160328000514 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Siddarth Puri |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1568718401 PECOS PAC ID: 3971801523 Enrollment ID: I20160414000738 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Amy Christina Woods |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1699193623 PECOS PAC ID: 5496053605 Enrollment ID: I20160420002040 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Reza Tadayon Nejad |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1326329012 PECOS PAC ID: 6800010992 Enrollment ID: I20160630002254 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Brinda S Krishnan |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1114970076 PECOS PAC ID: 1759369549 Enrollment ID: I20160808002158 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Joshua Mark Flatow |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1487996302 PECOS PAC ID: 9335434430 Enrollment ID: I20160829002196 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Larry Ozowara |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1295046407 PECOS PAC ID: 5092038927 Enrollment ID: I20160906002285 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Karen Lai |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1710304910 PECOS PAC ID: 5395024780 Enrollment ID: I20161107001794 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Yehonatan Borenstein |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1386063089 PECOS PAC ID: 2769762178 Enrollment ID: I20161130002381 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Earl Andrew Balayan De Guzman |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1821432378 PECOS PAC ID: 8628358801 Enrollment ID: I20161205001169 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Heather Lewerenz |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1891902698 PECOS PAC ID: 9335439082 Enrollment ID: I20170215001558 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Kamaldeep S Sandhu |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1629483219 PECOS PAC ID: 2466731120 Enrollment ID: I20170222002126 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Benjamin R Berry |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1033536073 PECOS PAC ID: 5496028029 Enrollment ID: I20170901002847 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Adham Nabil Malaty |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1174818587 PECOS PAC ID: 6002039351 Enrollment ID: I20171012001046 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Frank Massey |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1699821207 PECOS PAC ID: 1557496148 Enrollment ID: I20171116001882 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Alejandro Perez |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1275951832 PECOS PAC ID: 9537426846 Enrollment ID: I20171121002754 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Stefana B Morgan |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1649698101 PECOS PAC ID: 5395024467 Enrollment ID: I20171218002071 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Alberto G Lopez |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1497955637 PECOS PAC ID: 3375803638 Enrollment ID: I20180205002849 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Katherine Cole |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1447469192 PECOS PAC ID: 1850487406 Enrollment ID: I20180208002959 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Douglas Chen |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1336280023 PECOS PAC ID: 7416109012 Enrollment ID: I20180521000997 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Jill K Norman |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1366817983 PECOS PAC ID: 0042575763 Enrollment ID: I20180530002659 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Vikram Malhotra |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1033407986 PECOS PAC ID: 1254588148 Enrollment ID: I20180530003220 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Sateesh K Gunda |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1134407844 PECOS PAC ID: 2466764881 Enrollment ID: I20180611001811 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Brian T Anderson |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1184042699 PECOS PAC ID: 0840588968 Enrollment ID: I20180615001979 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Beverly Ann Reader |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1396937868 PECOS PAC ID: 6406913631 Enrollment ID: I20180619002900 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Brian Keith Sparks |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1780940403 PECOS PAC ID: 6305193434 Enrollment ID: I20180720001563 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Sarbani Maitra |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1134360647 PECOS PAC ID: 0244597318 Enrollment ID: I20180720002947 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Chase R Warren |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1992140040 PECOS PAC ID: 0648528851 Enrollment ID: I20180803002547 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Jacob A Leivent |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1326452756 PECOS PAC ID: 1557629284 Enrollment ID: I20180817002244 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Nina Vasan |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1952749418 PECOS PAC ID: 7113277245 Enrollment ID: I20180911000773 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Alexander Thanh Nguyen |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1821330069 PECOS PAC ID: 0042560906 Enrollment ID: I20180913003078 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Neha P Chaudhary |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1720346315 PECOS PAC ID: 1850685280 Enrollment ID: I20180928002702 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Chris Chen |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1710306345 PECOS PAC ID: 8820342900 Enrollment ID: I20181107003013 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Dana M Arlien |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1760506927 PECOS PAC ID: 0446309181 Enrollment ID: I20181108000799 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Megan P Della Selva |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1306145016 PECOS PAC ID: 7416256441 Enrollment ID: I20181113003301 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Katherine Rachel Roberts |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1740607019 PECOS PAC ID: 4284996331 Enrollment ID: I20181129000216 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Madison Mb Johnson |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1679993083 PECOS PAC ID: 1254675218 Enrollment ID: I20181130002339 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Rupinder K Legha |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1578799680 PECOS PAC ID: 5597938381 Enrollment ID: I20181204000942 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Gowri G Aragam |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1336552439 PECOS PAC ID: 6608094925 Enrollment ID: I20181205002937 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Anjali L Varigonda |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1942629894 PECOS PAC ID: 4082916671 Enrollment ID: I20181206000202 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | John P Daly |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1174950992 PECOS PAC ID: 5799029492 Enrollment ID: I20181206003248 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | John Teal |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1972897999 PECOS PAC ID: 6204095284 Enrollment ID: I20181210002921 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Joshua Kane |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1033271747 PECOS PAC ID: 9638205875 Enrollment ID: I20181214001924 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Zahra Naqvi |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1568881423 PECOS PAC ID: 8628313566 Enrollment ID: I20181220000914 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Kurt N Johnson |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1063830149 PECOS PAC ID: 3476774563 Enrollment ID: I20181226001917 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Tarek Adam |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1053722736 PECOS PAC ID: 3870838311 Enrollment ID: I20190102002559 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Ladan Hariri |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1689022477 PECOS PAC ID: 4587909023 Enrollment ID: I20190102002661 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Shakevia V Johnson |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1104236850 PECOS PAC ID: 5092008052 Enrollment ID: I20190107000277 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | David S Grunwald |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1437592623 PECOS PAC ID: 7012238553 Enrollment ID: I20190207001669 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Jeffrey B Caplan |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1629182969 PECOS PAC ID: 2567547375 Enrollment ID: I20190212000979 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Andrew F Archer |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1447670245 PECOS PAC ID: 2466672811 Enrollment ID: I20190529002509 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Dyani Loo |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1245573476 PECOS PAC ID: 7214168681 Enrollment ID: I20190722001333 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Marcel Green |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1891076329 PECOS PAC ID: 2961776117 Enrollment ID: I20191010001475 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Mario A Mangiardi |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1023490828 PECOS PAC ID: 6507198371 Enrollment ID: I20191028002149 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Nolan Williams |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1811339641 PECOS PAC ID: 5991939282 Enrollment ID: I20200407002635 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Kairav Rameshchandra Shah |
|---|---|
| Provider Type | Practitioner - Interventional Pain Management |
| Provider Identifiers | NPI Number: 1053660886 PECOS PAC ID: 7911123740 Enrollment ID: I20200706001363 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Ritika Kaula |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1588045140 PECOS PAC ID: 6507179835 Enrollment ID: I20200727003225 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Felix E Kral |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1306985114 PECOS PAC ID: 2567436447 Enrollment ID: I20200831000441 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Bradley Dane Brown |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1639559677 PECOS PAC ID: 3971807587 Enrollment ID: I20200929001122 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Samuel B Viglietta |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1679937759 PECOS PAC ID: 6103163142 Enrollment ID: I20201103001943 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Balveen Singh |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1164753745 PECOS PAC ID: 4183809718 Enrollment ID: I20201229002862 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Kimberlee Wilson |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1306134929 PECOS PAC ID: 3678890563 Enrollment ID: I20210625001428 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Deniz Doruk Camsari |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1043674716 PECOS PAC ID: 5890087951 Enrollment ID: I20210913000784 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Raghu Kiran Appasani |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1023594850 PECOS PAC ID: 2163812504 Enrollment ID: I20211129002623 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Mercy Perdomo Rodriguez |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1376997502 PECOS PAC ID: 3072808054 Enrollment ID: I20211206000789 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Gurmehr Kaur |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1417452913 PECOS PAC ID: 4284031683 Enrollment ID: I20220523000735 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Tyler J Torrico |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1083243125 PECOS PAC ID: 2365810793 Enrollment ID: I20221116001285 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Tony Thomas Abraham |
|---|---|
| Provider Type | Practitioner - General Practice |
| Provider Identifiers | NPI Number: 1609432061 PECOS PAC ID: 5193115830 Enrollment ID: I20230403002564 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Hadijat Wemmy Audu |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1013544790 PECOS PAC ID: 2365807153 Enrollment ID: I20230501001253 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Ramail Danish Siddiqui |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1366061194 PECOS PAC ID: 5698153625 Enrollment ID: I20230918002702 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Simon A Allo |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1780204214 PECOS PAC ID: 2062866510 Enrollment ID: I20231002003175 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
| Provider Name | Kyle Hendrie |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1720549827 PECOS PAC ID: 1658607205 Enrollment ID: I20231218000588 |
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
News Archive
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The gene mutation is called the BDNF Val66Met allele, or just the Met allele.
A wide variety of experiments have shown that nanoscale quantum dots have the potential to detect early-stage cancer and even monitor the progress of anticancer therapies.
› Verified 8 days ago
Clb Associates Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 400 W 3rd St, D-250, Santa Rosa, CA 95401 Phone: 707-566-7571 | |
Sonoma County Indian Health Project Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 144 Stony Point Rd, Santa Rosa, CA 95401 Phone: 707-521-4545 | |
Cross Cultural Services And Evaluations, Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1550 Airport Blvd Ste 206, Santa Rosa, CA 95403 Phone: 707-799-4274 | |
Mounir Belcadi, Md Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 3452 Mendocino Ave, Suite C, Santa Rosa, CA 95403 Phone: 707-579-8703 Fax: 707-579-8755 | |
Drug Abuse Alternatives Center Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2403 Professional Dr, Santa Rosa, CA 95403 Phone: 707-544-3295 | |
Surgical Neuromonitoring Service Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 3005 Santa Margarita Ct, Santa Rosa, CA 95405 Phone: 707-573-2341 Fax: 707-539-2939 | |
Lifeworks Of Sonoma County Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1260 N Dutton Ave Ste 220, Santa Rosa, CA 95401 Phone: 707-568-2300 Fax: 707-568-2304 |